Michiel C. Verboom

Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

Jacqueline S. L. Kloth, Alessia Pagani, Michiel C. Verboom et al. · British Journal of Cancer · 2015 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Tissue factor associates with survival and regulates tumour progression in osteosarcoma

Chris Tieken, Michiel C. Verboom, Wolfram Ruf et al. · Thrombosis and Haemostasis · 2016 · 30 citations · Full text

Medicine, Cancer Biology, Pathobiology +16

Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib

Michiel C. Verboom, Jacqueline S. L. Kloth, Jesse J. Swen et al. · European Journal of Cancer · 2017 · 26 citations · Full text

Medicine, Genetics, Oncology +15

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

Michiel C. Verboom, Jan Ouwerkerk, Neeltje Steeghs et al. · Clinical Sarcoma Research · 2017 · 20 citations · Full text

Medicine, Oncology, Surgery +16

Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib

Jacqueline S. L. Kloth, Michiel C. Verboom, Jesse J. Swen et al. · The Pharmacogenomics Journal · 2017 · 15 citations · Full text

Medicine, Genetics, Oncology +16